SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-449447
Filing Date
2014-12-22
Accepted
2014-12-22 06:33:38
Documents
8
Period of Report
2014-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d839488d8k.htm 8-K 55074
2 EX-10.1 d839488dex101.htm EX-10.1 719028
3 EX-10.2 d839488dex102.htm EX-10.2 873205
4 EX-10.3 d839488dex103.htm EX-10.3 1127744
5 EX-10.4 d839488dex104.htm EX-10.4 924426
6 EX-10.5 d839488dex105.htm EX-10.5 950267
7 GRAPHIC g839488actavis_logo.jpg GRAPHIC 14892
8 GRAPHIC g839488ex10_4pg001.jpg GRAPHIC 16544
  Complete submission text file 0001193125-14-449447.txt   4694745
Mailing Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2
Business Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2 (216) 523-5000
Actavis plc (Filer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55075 | Film No.: 141301552
SIC: 2834 Pharmaceutical Preparations